Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer

Overview of attention for article published in Frontiers in Pharmacology, May 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,883 followers.

New Research: Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer https://t.co/exh4B338QZ #pharmacology

03 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.